This announcement is a separate document:
威尔药业2021年限制性股票激励计划第三个解除限售期解除限售条件成就相关事项的法律意见书
Legal opinion regarding the achievements of the relevant matters of the third lifting of the restricted stock incentive plan of Nanjing Well Pharmaceutical Group in 2021.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.